TNDMTANDEM DIABETES CARE INC

Nasdaq tandemdiabetes.com


$ 35.22 $ -0.32 (-0.9 %)    

Friday, 26-Apr-2024 15:59:57 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 35.24
$ 35.20
$ 0.00 x 0
$ 0.00 x 0
$ 34.78 - $ 35.77
$ 13.82 - $ 40.74
783,779
na
2.29B
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-21-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-22-2023 12-31-2022 10-K
6 11-02-2022 09-30-2022 10-Q
7 08-03-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-22-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 02-24-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 07-30-2020 06-30-2020 10-Q
16 04-30-2020 03-31-2020 10-Q
17 02-24-2020 12-31-2019 10-K
18 11-04-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 04-30-2019 03-31-2019 10-Q
21 02-26-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 07-30-2018 06-30-2018 10-Q
24 04-26-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 10-26-2017 09-30-2017 10-Q
27 07-27-2017 06-30-2017 10-Q
28 04-27-2017 03-31-2017 10-Q
29 03-08-2017 12-31-2016 10-K
30 11-01-2016 09-30-2016 10-Q
31 07-28-2016 06-30-2016 10-Q
32 04-28-2016 03-31-2016 10-Q
33 02-24-2016 12-31-2015 10-K
34 10-29-2015 09-30-2015 10-Q
35 07-30-2015 06-30-2015 10-Q
36 04-30-2015 03-31-2015 10-Q
37 02-24-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 07-31-2014 06-30-2014 10-Q
40 05-06-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 leerink-partners-upgrades-tandem-diabetes-care-to-outperform-raises-price-target-to-45

Leerink Partners analyst Mike Kratky upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Market Perform to Outperform and raise...

 stifel-maintains-buy-on-tandem-diabetes-care-raises-price-target-to-40

Stifel analyst Mathew Blackman maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and raises the price target from $37 ...

 citigroup-maintains-neutral-on-tandem-diabetes-care-raises-price-target-to-38

Citigroup analyst Joanne Wuensch maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target fro...

 stocks-inch-higher-tesla-rebounds-bitcoin-holds-below-70000-whats-driving-markets-tuesday

Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in Ne...

 tesla-krispy-kreme-mccormick-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.

 stifel-upgrades-tandem-diabetes-care-to-buy-raises-price-target-to-37

Stifel analyst Mathew Blackman upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Hold to Buy and raises the price target from...

 stifel-upgrades-tandem-diabetes-care-to-buy-announces-37-price-target

Stifel analyst Mathew Blackman upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Hold to Buy and announces $37 price target.

 citigroup-maintains-neutral-on-tandem-diabetes-care-raises-price-target-to-31

Citigroup analyst Joanne Wuensch maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target fro...

 why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

 tandem-diabetes-care-announces-proposed-250m-private-placement-of-convertible-notes-due-2029

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced today that it in...

 why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

 carvana-posts-q4-results-joins-legalzoomcom-comfort-systems-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.

 tandem-diabetes-care-q4-2023-gaap-eps-046-misses-027-estimate-sales-19680m-miss-20276m-estimate

Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION